Free Trial

Genus (LON:GNS) Receives "Buy" Rating from Shore Capital

Genus logo with Medical background

Shore Capital reiterated their buy rating on shares of Genus (LON:GNS - Free Report) in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports.

Genus Trading Up 0.1 %

Shares of Genus stock traded up GBX 2.13 ($0.03) on Wednesday, hitting GBX 1,644.13 ($21.01). The stock had a trading volume of 661,456 shares, compared to its average volume of 122,658. The stock has a 50 day moving average of GBX 1,907.74 and a 200 day moving average of GBX 1,822.87. The firm has a market capitalization of £1.08 billion, a P/E ratio of 13,828.00, a PEG ratio of 2.87 and a beta of 0.37. Genus has a twelve month low of GBX 1,478 ($18.88) and a twelve month high of GBX 2,378 ($30.38). The company has a debt-to-equity ratio of 53.54, a quick ratio of 1.08 and a current ratio of 1.80.

Insider Activity

In other news, insider Jorgen Kokke sold 2,186 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($24.99), for a total transaction of £42,758.16 ($54,629.05). Insiders own 0.75% of the company's stock.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Articles

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines